Real-time fluorescence imaging for visualization and drug uptake prediction during drug delivery by thermosensitive liposomes

References

• Wilhelm S, Tavares AJ, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1:16014.
   Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20–37.
   PubMed Web of Science ®Google Scholar
• Gasselhuber A, Dreher MR, Rattay F, et al. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model. PLoS One. 2012;7:e47453.
   PubMed Web of Science ®Google Scholar
• Seynhaeve AL, Dicheva BM, Hoving S, et al. Intact doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging. J Control Release. 2013;172:330–340.
   PubMed Web of Science ®Google Scholar
• Kneidl B, Peller M, Winter G, et al. Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomed. 2014;9:4387–4398.
   PubMed Web of Science ®Google Scholar
• Haemmerich D, Motamarry A. Thermosensitive liposomes for image-guided drug delivery. Adv Cancer Res. 2018;139:121–146.
   PubMed Web of Science ®Google Scholar
• Li L, ten Hagen TL, Schipper D, et al. Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J Control Release. 2010;143:274–279.
   PubMed Web of Science ®Google Scholar
• Manzoor AA, Lindner LH, Landon CD, et al. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res. 2012;72:5566–5575.
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Cancer Res. 2000;60:6950–6957.
   PubMed Web of Science ®Google Scholar
• Mikhail AS, Negussie AH, Pritchard WF, et al. Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer. Int J Hypertherm. 2017;33:733–740.
   PubMed Web of Science ®Google Scholar
• Kheirolomoom A, Lai C-Y, Tam SM, et al. Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia. J Control Release. 2013;172:266–273.
   PubMed Web of Science ®Google Scholar
• Andriyanov AV, Koren E, Barenholz Y, et al. Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (rf) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes. PLoS One. 2014;9:e92555.
   PubMed Web of Science ®Google Scholar
• Wood BJ, Poon RT, Locklin JK, et al. Phase i study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol. 2012;23:248–255.e7.
   PubMed Web of Science ®Google Scholar
• Zagar TM, Vujaskovic Z, Formenti S, et al. Two phase i dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (ltld) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer. Int J Hypertherm. 2014;30:285–294.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Cioni D. Rfa plus lyso-thermosensitive liposomal doxorubicin: In search of the optimal approach to cure intermediate-size hepatocellular carcinoma. Hepatic Oncol. 2016;3:193.
   PubMed Web of Science ®Google Scholar
• Dou Y, Hynynen K, Allen C. To heat or not to heat: challenges with clinical translation of thermosensitive liposomes. J Control Release. 2017;249:63–73.
   PubMed Web of Science ®Google Scholar
• Motamarry A, Asemani D, Haemmerich D. Thermosensitive liposomes. In: Catala A, editor. Liposomes. Rijeka: InTech, 2017. Ch. 07.
   Google Scholar
• Lyon PC, Gray MD, Mannaris C, et al. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (tardox): a single-centre, open-label, phase 1 trial. Lancet Oncol. 2018;19:1027–1039.
   PubMed Web of Science ®Google Scholar
• Willerding L, Limmer S, Hossann M, et al. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors. J Control Release. 2016;222:47–55.
   PubMed Web of Science ®Google Scholar
• Rossmann C, McCrackin MA, Armeson KE, et al. Temperature sensitive liposomes combined with thermal ablation: effects of duration and timing of heating in mathematical models and in vivo. PLoS One. 2017;12:e0179131.
   PubMed Web of Science ®Google Scholar
• Bing C, Patel P, Staruch RM, et al. Longer heating duration increases localized doxorubicin deposition and therapeutic index in vx2 tumors using mr-hifu mild hyperthermia and thermosensitive liposomal doxorubicin. Int J Hypertherm. 2019;36:196–203.
   PubMed Web of Science ®Google Scholar
• Hijnen N, Langereis S, Grull H. Magnetic resonance guided high-intensity focused ultrasound for image-guided temperature-induced drug delivery. Adv Drug Deliv Rev. 2014;72:65–81.
   PubMed Web of Science ®Google Scholar
• Hijnen N, Kneepkens E, de Smet M, et al. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound. Proc Natl Acad Sci USA. 2017;114:E4802–e11.
   PubMed Web of Science ®Google Scholar
• Li L, ten Hagen TL, Haeri A, et al. A novel two-step mild hyperthermia for advanced liposomal chemotherapy. J Control Release. 2014;174:202–208.
   PubMed Web of Science ®Google Scholar
• Chen MM, Liu YY, Su GH, et al. Nir responsive liposomal system for rapid release of drugs in cancer therapy. IJN. 2017;12:4225–4239.
   Web of Science ®Google Scholar
• Li L, ten Hagen TL, Bolkestein M, et al. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia. J Control Release. 2013;167:130–137.
   PubMed Web of Science ®Google Scholar
• Dicheva BM, ten Hagen TL, Schipper D, et al. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes. J Control Release. 2014;195:37–48.
   PubMed Web of Science ®Google Scholar
• Santos MA, Goertz DE, Hynynen K. Focused ultrasound hyperthermia mediated drug delivery using thermosensitive liposomes and visualized with in vivo two-photon microscopy. Theranostics. 2017;7:2718–2731.
   PubMed Web of Science ®Google Scholar
• Palmer GM, Boruta RJ, Viglianti BL, et al. Non-invasive monitoring of intra-tumor drug concentration and therapeutic response using optical spectroscopy. J Control Release. 2010;142:457–464.
   PubMed Web of Science ®Google Scholar
• Tak WY, Lin SM, Wang Y, et al. Phase iii heat study adding lyso-thermosensitive liposomal doxorubicin to radiofrequency ablation in patients with unresectable hepatocellular carcinoma lesions. Clin Cancer Res. 2018;24:73–83.
   PubMed Web of Science ®Google Scholar
• Needham D, Anyarambhatla G, Kong G, et al. A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model. Cancer Res. 2000;60:1197–1201.
   PubMed Web of Science ®Google Scholar
• Negussie AH, Yarmolenko PS, Partanen A, et al. Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Int J Hypertherm. 2011;27:140–155.
   PubMed Web of Science ®Google Scholar
• Burke C, Dreher MR, Negussie AH, et al. Drug release kinetics of temperature sensitive liposomes measured at high-temporal resolution with a millifluidic device. Int J Hyperthermia. 2018;34:786–794.
   PubMed Web of Science ®Google Scholar
• Asemani D, Motamarry A, Haemmerich D. In vitro measurement of release kinetics of temperature sensitive liposomes with a fluorescence imaging system. Proceedings of 40th IEEE Engineering in Medicine and Biology Society; 2018 Jul 17–21; Honolulu, Hawaii; p. 3216–3219.
   Google Scholar
• Gaber MH, Wu NZ, Hong K, et al. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys. 1996;36:1177–1187.
   PubMed Web of Science ®Google Scholar
• Bredlau AL, Motamarry A, Chen C, et al. Localized delivery of therapeutic doxorubicin dose across the canine blood-brain barrier with hyperthermia and temperature sensitive liposomes. Drug Deliv. 2018;25:973–984.
   PubMed Web of Science ®Google Scholar
• Ranjan A, Jacobs GC, Woods DL, et al. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit vx2 tumor model. J Control Release. 2012;158:487–494.
   PubMed Web of Science ®Google Scholar
• Fiebig K, Jourdan T, Kock MH, et al. Evaluation of infrared thermography for temperature measurement in adult male NMRI nude mice. J Am Assoc Lab Anim Sci. 2018.
   PubMed Web of Science ®Google Scholar
• Banno B, Ickenstein LM, Chiu GNC, et al. The functional roles of poly(ethylene glycol)‐lipid and lysolipid in the drug retention and release from lysolipid‐containing thermosensitive liposomes in vitro and in vivo. J Pharmaceut Sci. 2010;99:2295–2308.
   PubMed Web of Science ®Google Scholar
• Rikke BA, Johnson TE. Lower body temperature as a potential mechanism of life extension in homeotherms. Exp Gerontol. 2004;39:927–930.
   PubMed Web of Science ®Google Scholar
• Yatvin MB, Weinstein JN, Dennis WH, et al. Design of liposomes for enhanced local release of drugs by hyperthermia. Science. 1978;202:1290–1293.
   PubMed Web of Science ®Google Scholar
• Lindner LH, Eichhorn ME, Eibl H, et al. Novel temperature-sensitive liposomes with prolonged circulation time. Clin Cancer Res. 2004;10:2168–2178.
   PubMed Web of Science ®Google Scholar
• Lu T, Lokerse WJ, Seynhaeve AL, et al. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response. J Control Release. 2015;220:425–437.
   PubMed Web of Science ®Google Scholar
• Li L, Ten Hagen TL, Hossann M, et al. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release. 2013;168:142–150.
   PubMed Web of Science ®Google Scholar
• Miller MA, Askevold B, Yang KS, et al. Platinum compounds for high-resolution in vivo cancer imaging. ChemMedChem. 2014;9:1131–1135.
   PubMed Web of Science ®Google Scholar
• Ponce AM, Viglianti BL, Yu D, et al. Magnetic resonance imaging of temperature-sensitive liposome release: Drug dose painting and antitumor effects. J Natl Cancer Inst. 2007;99:53–63.
   PubMed Web of Science ®Google Scholar
• Peller M, Willerding L, Limmer S, et al. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors. J Control Release. 2016;237:138–146.
   PubMed Web of Science ®Google Scholar
• Kneepkens E, Heijman E, Keupp J, et al. Interleaved mapping of temperature and longitudinal relaxation rate to monitor drug delivery during magnetic resonance-guided high-intensity focused ultrasound-induced hyperthermia. Invest Radiol. 2017;52:620–630.
   PubMed Web of Science ®Google Scholar